本頁面由Tiger Trade Technology Pte. Ltd.提供服務

奧麥羅製藥

18.28
-0.3100-1.67%
盤後18.27-0.0100-0.05%19:56 EDT
成交量:101.43萬
成交額:1,871.34萬
市值:13.23億
市盈率:11.63
高:18.98
開:18.74
低:18.28
收:18.59
52周最高:19.65
52周最低:3.94
股本:7,237.54萬
流通股本:6,825.80萬
量比:0.87
換手率:1.49%
股息:- -
股息率:- -
每股收益(TTM):1.57
每股收益(LYR):-0.0527
淨資產收益率:-576.33%
總資產收益率:-18.68%
市淨率:-25.77
市盈率(LYR):-346.56

資料載入中...

2021/05/20

重要事件披露

8-K - Current report
2021/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/01

重要事件披露

8-K - Current report
2021/02/17

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/09

重要事件披露

8-K - Current report
2020/08/14

重要事件披露

8-K - Current report
2020/08/12

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/10

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/10

重要事件披露

8-K - Current report
2020/06/11

重要事件披露

8-K - Current report